Improved oral bioavailability of magnolol by using a binary mixed micelle system

Area of Science:

• Pharmaceutical Sciences
• Materials Science
• Biotechnology

Background:

• Magnolol (MO) exhibits poor aqueous solubility and low oral bioavailability, limiting its therapeutic applications.
• Development of advanced drug delivery systems is crucial for enhancing the efficacy of poorly soluble drugs like magnolol.

Purpose of the Study:

• To prepare and characterize novel magnolol-loaded binary mixed micelles (MO-M) using biocompatible copolymers.
• To improve the solubility and oral bioavailability of magnolol through micellar formulation.

Main Methods:

• Binary mixed micelles (MO-H and MO-T) were prepared using Soluplus (SOL) with Solutol® HS15 (HS15) or TPGS via organic solvent evaporation.
• Micelles were characterized for morphology (TEM), entrapment efficiency (EE%), drug loading (DL%), and dilution stability.
• In vitro permeability studies using Caco-2 cell monolayers and in vivo pharmacokinetic studies were conducted.

Main Results:

• Both MO-H and MO-T micelles exhibited high entrapment efficiency and drug loading, with MO-H showing slightly higher values.
• Transmission electron microscopy confirmed homogeneous, spherical micelle morphology.
• Mixed micelles demonstrated enhanced permeability across Caco-2 cells and significantly increased oral bioavailability of magnolol (2.39-fold for MO-T, 2.98-fold for MO-H).

Conclusions:

• Novel magnolol-loaded mixed micelles formulated with SOL/HS15 or SOL/TPGS are effective in overcoming the poor solubility and bioavailability challenges of magnolol.
• These mixed micelles represent a promising drug delivery system for improving oral drug absorption and therapeutic outcomes.